Skip to main content

Sodium Polystyrene Sulfonate

NDC 62135-340 · Chartwell RX, LLC

Generic nameSodium Polystyrene Sulfonate
Dosage formPOWDER, FOR SUSPENSION
RouteORAL, RECTAL
Active ingredient(s)SODIUM POLYSTYRENE SULFONATE
Strength4.1 meq/g
Marketing categoryANDA

Packages

62135-340-11 — 10 BOTTLE in 1 BOX (62135-340-11) / 15 g in 1 BOTTLE

62135-340-53 — 453.6 g in 1 BOTTLE (62135-340-53)

62135-340-62 — 15 g in 1 BOTTLE (62135-340-62)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

10702-036 — Sodium Polystyrene Sulfonate, 11534-166 — sodium polystyrene sulfonate, 17856-0024 — Sodium Polystyrene Sulfonate, 24658-760 — Sodium Polystyrene Sulfonate, 35573-108 — sodium polystyrene sulfonate, 42806-013 — Sodium Polystyrene Sulfonate, 46287-006 — sodium polystyrene sulfonate, 46287-012 — Sodium Polystyrene Sulfonate, 55154-7353 — sodium polystyrene sulfonate, 62559-356 — Sodium Polystyrene Sulfonate, 63083-9320 — Industrial Combination, 63629-2390 — sodium polystyrene sulfonate, 63629-8849 — sodium polystyrene sulfonate, 63629-8850 — sodium polystyrene sulfonate, 71335-2855 — sodium polystyrene sulfonate, 72162-1230 — sodium polystyrene sulfonate

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels